Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Pancreatic Cancer Clinical Trials in Miami | 121 Studies

Clinical Trials Pancreatic CancerMiami

Pancreatic Cancer Clinical Trials in Miami

Find 121 clinical trials for pancreatic cancer near Miami, Florida. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Miami

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 121 trials

RecruitingA Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyThe purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated…NCT03394365·Duarte, California and 70 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedQUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerThis is a multi-center, 2-part study of AMG 655, AMG 479 or AMG 655-placebo plus gemcitabine as first-line treatment of subjects with metastatic pancreatic cancer.NCT00630552·Alhambra, California and 43 others

RecruitingcfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseThis is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differentiate amongst cancer…NCT05366881·Duarte, California and 16 others

CompletedNab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)The purpose of this study is to compare whether there is a delay or prevention of recurrence or death in participants with surgically removed pancreatic cancer who then take…NCT01964430·Scottsdale, Arizona and 340 others

RecruitingPancreatic Cancer Early Detection ConsortiumThe purpose of the Pancreatic Cancer Early Detection (PRECEDE) Consortium is to conduct research on multiple aspects of early detection and prevention of pancreatic ductal…NCT04970056·Phoenix, Arizona and 59 others

RecruitingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryInternational registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool…NCT03452774·Birmingham, Alabama and 67 others

CompletedA Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic CancerA study to evaluate AGS-1C4D4 administered in combination with Gemcitabine chemotherapy in subjects with Metastatic Pancreatic Cancer.NCT00902291·La Jolla, California and 35 others

CompletedCapecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic CancerRATIONALE: Drugs used in chemotherapy, such as capecitabine and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping…NCT00290693·Jacksonville, Florida and 2 others

CompletedStudy to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid SyndromeThe purpose of this study is to evaluate the safety, pharmacokinetics (PK), and exploratory dose response of paltusotine treatment in subjects with carcinoid syndrome.NCT05361668·Los Angeles, California and 34 others

TerminatedOpen-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesThe purpose of the Study is to select a dose and assess the safety and tolerability of INCB057643 as a monotherapy (Part 1 and Part 2) and in combination with standard-of-care…NCT02711137·Birmingham, Alabama and 17 others

RecruitingStudy of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.NCT07252232·Phoenix, Arizona and 77 others

Active not recruitingTesting the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA MutationsThis phase II trial studies whether adding pembrolizumab to olaparib (standard of care) works better than olaparib alone in treating patients with pancreatic cancer with germline…NCT04548752·Anchorage, Alaska and 532 others

Approved for marketingExpanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaThis Expanded Access Program (EAP) is intended to provide daraxonrasib to eligible adult patients with previously treated metastatic pancreatic adenocarcinoma, who have no…NCT07573215·Birmingham, Alabama and 256 others

TerminatedA Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsThis study will evaluate the efficacy and safety of alectinib in participants with Anaplastic Lymphoma Kinase (ALK)-positive locally advanced or metastatic solid tumors other than…NCT04644315·Culver City, California and 28 others

CompletedGemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by SurgeryThis randomized phase II-R/III trial studies gemcitabine hydrochloride with or without erlotinib hydrochloride followed by the same chemotherapy regimen with or without radiation…NCT01013649·Mobile, Alabama and 688 others

CompletedTTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced CancersThis is a phase 1/1b study of TTX-030 in combination therapy, an antibody that inhibits CD39 enzymatic activity, leading to accumulation of pro-inflammatory adenosine triphosphate…NCT04306900·Scottsdale, Arizona and 31 others

CompletedClinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic CancerThis is a case-control study to clinically validate the performance of a protein biomarker test to differentiate Stage I and Stage II pancreatic ductal adenocarcinoma (PDAC)…NCT06947382·Scottsdale, Arizona and 14 others

CompletedA Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.Definition: This study will compare the drug GEMZAR to a combination of GEMZAR plus ALIMTA for the treatment of cancer of the pancreas.NCT00035035·Huntsville, Alabama and 113 others

TerminatedStudy of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid TumorsPhase Ib dose escalation in advanced solid tumors to identify dose for Phase II dose expansion in advanced or metastatic pancreatic cancer and KRAS-mutant colorectal cancer.NCT02703571·Fayetteville, Arkansas and 14 others

RecruitingTesting the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsThis phase II trial studies the effect of capecitabine and temozolomide after surgery in treating patients with high-risk well-differentiated pancreatic neuroendocrine tumors.NCT05040360·Anchorage, Alaska and 447 others

PreviousPage 4 of 7Next

Other Conditions in Miami

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia